Six Concourse Parkway
Suite 3300
Atlanta, GA 30328
(770) 829-6200
Mellon Investor Services LLC is the transfer agent for the Companys common stock and is responsible for maintaining shareholder account records. Inquiries regarding account records, lost certificates, address changes or other related issues should be directed to:
Mellon Investor Services LLC
85 Challenger Road
Ridgefield Park, NJ 07660
(800) 851-9677
www.melloninvestor.com
On August 19, 2004, in accordance with Section 303A.12 of the Listed Company Manual, our Chief Executive Officer certified to the New York Stock Exchange that he was not aware of any violation by the Company of NYSE corporate governance listing standards as of such date. In addition, on December 14, 2004, our Chief Executive Officer and Chief Financial Officer each filed a certification under Section 302 of the Sarbanes-Oxley Act relating to the quality of the Companys public disclosure as exhibits to the Companys Annual Report on Form 10-K for fiscal year 2004.
|
Rayovacs common stock is listed on the New York Stock Exchange under the symbol ROV. The following table sets forth the reported high and low prices per share of the common stock as reported on the New York Stock Exchange composite transactions reporting system for the periods indicated:
|
|
High |
Low |
| Quarter ended September 30, 2004 | $ | 30.95 | $ | 22.63 |
Quarter ended June 27, 2004 | $ | 30.30 | $ | 23.75 |
Quarter ended March 28, 2004 | $ | 27.80 | $ | 20.00 |
Quarter ended December 28, 2003 | $ | 21.77 | $ | 14.38 |
|
| Quarter ended September 30, 2003 |
$ | 15.75 |
$ | 12.68 |
| Quarter ended June 29, 2003 |
$ | 13.84 |
$ | 9.93 |
| Quarter ended March 30, 2003 |
$ | 14.49 |
$ | 10.50 |
| Quarter ended December 29, 2002 |
$ | 16.28 |
$ | 11.20 |
We have not declared or paid and do not anticipate paying cash dividends in the foreseeable future, but intend to retain any future earnings for reinvestment in our business. In addition, the terms of our credit facility restrict our ability to pay dividends to our shareholders.
Inquiries from securities analysts and others seeking financial information should be directed to Nancy ODonnell, Vice President of Investor Relations, at (770) 829-6200, or at investorrelations@rayovac.com.
Shareholders and others will find the Companys financial information, news releases and other information on the Investor Relations section of the Companys website at www.rayovac.com. There is a direct link from the website to the Companys filings with the Securities and Exchange Commission, including Forms 10-K, 10-Q, and 8-K. Investors may also request information about Rayovac and printed copies of documents released by the Company at investorrelations@rayovac.com.
This annual report contains forward-looking statements that involve risks and uncertainties, and actual results could differ materially. These risks and uncertainties are detailed in the Managements Discussion and Analysis section in the Companys Annual Report on Form 10-K for the year ended September 30, 2004, and other filings with the Securities and Exchange Commission.
|